422 reports of this reaction
2.9% of all MICONAZOLE NITRATE reports
#7 most reported adverse reaction
VULVOVAGINAL DISCOMFORT is the #7 most commonly reported adverse reaction for MICONAZOLE NITRATE, manufactured by H E B. There are 422 FDA adverse event reports linking MICONAZOLE NITRATE to VULVOVAGINAL DISCOMFORT. This represents approximately 2.9% of all 14,417 adverse event reports for this drug.
Patients taking MICONAZOLE NITRATE who experience vulvovaginal discomfort should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
VULVOVAGINAL DISCOMFORT is a less commonly reported adverse event for MICONAZOLE NITRATE, but still significant enough to appear in the safety profile.
In addition to vulvovaginal discomfort, the following adverse reactions have been reported for MICONAZOLE NITRATE:
The following drugs have also been linked to vulvovaginal discomfort in FDA adverse event reports:
VULVOVAGINAL DISCOMFORT has been reported as an adverse event in 422 FDA reports for MICONAZOLE NITRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
VULVOVAGINAL DISCOMFORT accounts for approximately 2.9% of all adverse event reports for MICONAZOLE NITRATE, making it a notable side effect.
If you experience vulvovaginal discomfort while taking MICONAZOLE NITRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.